All analyses were performed using IBM SPSS Statistics software (IBM Corp. IBM SPSS Statistics for Windows, Version 27.0, Armonk, NY, USA). For descriptive statistics, data were expressed as mean ± standard deviation. The study population was divided into two diagnosis groups (POTS, n = 59 and IST, n = 33). These diagnosis groups were subdivided according to COVID-19/vaccination-related patients, patients prior to the pandemic, and one healthy control group that was published and measured prior to the pandemic. An unpaired t-test was used to compare the differences between each patient group (Table 1). Significant group differences were anticipated if the p-value was <0.05. For the analysis of the impact of low-dose propranolol, ivabradine, and omega-3 fatty acid supplementation, we used a paired t-test at baseline in comparison to an active standing test after the introduction of these therapies (Table 2).
Free full text: Click here